These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 26438050)

  • 21. Classification Criteria For Pars Planitis.
    Standardization of Uveitis Nomenclature (SUN) Working Group
    Am J Ophthalmol; 2021 Aug; 228():268-274. PubMed ID: 33845006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic polymorphism of HLA DR in a Scottish population of patients with pars planitis.
    Greiner KH; Wilson DW; Thomson J; Kilmartin DJ; Urbaniak SJ; Forrester JV
    Eur J Ophthalmol; 2003 Jun; 13(5):433-8. PubMed ID: 12841565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intermediate uveitis.
    Bonfioli AA; Damico FM; Curi AL; Orefice F
    Semin Ophthalmol; 2005; 20(3):147-54. PubMed ID: 16282148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pars planitis in the Mexican Mestizo population: ocular findings, treatment, and visual outcome.
    Arellanes-García L; Navarro-López L; Recillas-Gispert C
    Ocul Immunol Inflamm; 2003 Mar; 11(1):53-60. PubMed ID: 12854027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The significance of the pars plana exudate in pars planitis.
    Henderly DE; Haymond RS; Rao NA; Smith RE
    Am J Ophthalmol; 1987 May; 103(5):669-71. PubMed ID: 3578463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated levels of interleukin 6 in the vitreous fluid of patients with pars planitis and posterior uveitis: the Massachusetts eye & ear experience and review of previous studies.
    Perez VL; Papaliodis GN; Chu D; Anzaar F; Christen W; Foster CS
    Ocul Immunol Inflamm; 2004 Sep; 12(3):193-201. PubMed ID: 15385196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pars planitis: epidemiology and clinical outcome in a large community hospital in Mexico City.
    Ortega-Larrocea G; Arellanes-Garcia L
    Int Ophthalmol; 1995; 19(2):117-20. PubMed ID: 8586494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intermediate Uveitis: A Review.
    Teo AYT; Betzler BK; Hua KLQ; Chen EJ; Gupta V; Agrawal R
    Ocul Immunol Inflamm; 2023 Jul; 31(5):1041-1060. PubMed ID: 35759636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Laser photocoagulation in intermediate uveitis associated with retinoschisis.
    Sızmaz S; Güngör SG; Bayar SA; Yılmaz G; Akkoyun I
    Ocul Immunol Inflamm; 2012 Oct; 20(5):372-4. PubMed ID: 22827157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pars planitis.
    Henderly DE; Genstler AJ; Rao NA; Smith RE
    Trans Ophthalmol Soc U K (1962); 1986; 105 ( Pt 2)():227-32. PubMed ID: 3467497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intermediate uveitis: what is the significance of the pars plana exudate in 'pars planitis'? A summary.
    Smith RE
    Dev Ophthalmol; 1992; 23():48-9. PubMed ID: 1730374
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical course of pars planitis in patients treated with selective photocoagulation].
    González Rubio-Medina E; Pedroza-Seres M
    Arch Soc Esp Oftalmol; 2013 Aug; 88(8):298-301. PubMed ID: 23886360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Vitrectomy surgery for the treatment of the vitreo-retinal complications of the pars planitis].
    Molina-Prat N; Adán AM; Mesquida M; Pelegrini L; Rey A; Alvarez G
    Arch Soc Esp Oftalmol; 2010 Oct; 85(10):333-6. PubMed ID: 21168058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vitreous hemorrhage is a common complication of pediatric pars planitis.
    Lauer AK; Smith JR; Robertson JE; Rosenbaum JT
    Ophthalmology; 2002 Jan; 109(1):95-8. PubMed ID: 11772586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peripheral Cryoablation for Treatment of Active Pars Planitis: Long-Term Outcomes of a Retrospective Study.
    Sohn EH; Chaon BC; Jabs DA; Folk JC
    Am J Ophthalmol; 2016 Feb; 162():35-42.e2. PubMed ID: 26576712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pars planitis: a 20-year study of incidence, clinical features, and outcomes.
    Donaldson MJ; Pulido JS; Herman DC; Diehl N; Hodge D
    Am J Ophthalmol; 2007 Dec; 144(6):812-817. PubMed ID: 18036872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Valsalva retinopathy: diagnostic challenges in a patient with pars-planitis.
    Androudi S; Ahmed M; Brazitikos P; Foster CS
    Acta Ophthalmol Scand; 2005 Apr; 83(2):256-7. PubMed ID: 15799745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of cyclitic membranes by ultrabiomicroscopy in patients with pars planitis.
    Concha Del Río LE; Duarte González GA; Mayorquín Ruiz M; Arellanes-García L
    J Ophthalmic Inflamm Infect; 2020 Jan; 10(1):7. PubMed ID: 31997032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibroglial proliferation in pars planitis.
    Kenyon KR; Pederson JE; Green WR; Maumenee AE
    Trans Ophthalmol Soc U K (1962); 1975; 95(3):391-7. PubMed ID: 1066857
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.